Protara Therapeutics, Inc. Earnings Per Share (Basic)
Protara Therapeutics, Inc. (TARA) reported Earnings Per Share (Basic) of -$0.36 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- Protara Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.36.
- Protara Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.31.
- Protara Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.31.
- Protara Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.35.
- Protara Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$1.34.
- Protara Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$2.17.
- Protara Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$3.57.
- Protara Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$5.86.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$0.36 10-Q · filed 2026-08-11 | -$0.67 10-Q · filed 2026-08-11 | |||
| 2026-03-31 | -$0.31 10-Q · filed 2026-05-13 | ||||
| 2025-12-31 | -$1.34 10-K · filed 2026-03-10 | ||||
| 2025-09-30 | -$0.31 10-Q · filed 2025-11-10 | -$0.96 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | -$0.35 10-Q · filed 2026-08-11 | -$0.65 10-Q · filed 2026-08-11 | |||
| 2025-03-31 | -$0.29 10-Q · filed 2026-05-13 | ||||
| 2024-12-31 | -$2.17 10-K · filed 2026-03-10 | ||||
| 2024-09-30 | -$0.50 10-Q · filed 2025-11-10 | -$1.74 10-Q · filed 2025-11-10 | |||
| 2024-06-30 | -$0.45 10-Q · filed 2025-08-11 | -$1.26 10-Q · filed 2025-08-11 | |||
| 2024-03-31 | -$0.97 10-Q · filed 2025-05-08 | ||||
| 2023-12-31 | -$0.90 derived: net income ÷ weighted average shares · filed 2025-03-05 | -$1.77 derived: net income ÷ weighted average shares · filed 2025-03-05 | -$4.36 derived: net income ÷ weighted average shares · filed 2025-03-05 | -$3.57 10-K · filed 2025-03-05 | |
| 2023-09-30 | -$0.87 10-Q · filed 2024-11-12 | -$3.46 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$2.67 10-Q · filed 2024-11-12 | -$6.12 derived: net income ÷ weighted average shares · filed 2024-11-12 | |
| 2023-06-30 | -$1.00 10-Q · filed 2024-08-06 | -$1.80 10-Q · filed 2024-08-06 | -$5.25 derived: net income ÷ weighted average shares · filed 2024-08-06 | -$5.94 derived: net income ÷ weighted average shares · filed 2024-08-06 | |
| 2023-03-31 | -$0.80 10-Q · filed 2024-05-02 | -$2.65 derived: net income ÷ weighted average shares · filed 2024-05-02 | -$3.33 derived: net income ÷ weighted average shares · filed 2024-05-02 | -$6.00 derived: net income ÷ weighted average shares · filed 2024-05-02 | |
| 2022-12-31 | -$3.46 derived: net income ÷ weighted average shares · filed 2024-03-13 | -$4.14 derived: net income ÷ weighted average shares · filed 2024-03-13 | -$6.81 derived: net income ÷ weighted average shares · filed 2024-03-13 | -$5.86 10-K · filed 2024-03-13 | |
| 2022-09-30 | -$0.68 10-Q · filed 2023-11-03 | -$3.35 derived: net income ÷ weighted average shares · filed 2023-11-03 | -$2.40 10-Q · filed 2023-11-03 | ||
| 2022-06-30 | -$0.76 10-Q · filed 2023-08-03 | -$0.80 10-Q · filed 2022-08-09 | -$1.71 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | -$0.96 10-Q · filed 2023-05-04 | ||||
| 2021-12-31 | -$4.21 10-K · filed 2023-03-08 | ||||
| 2021-09-30 | -$0.96 10-Q · filed 2022-11-03 | -$3.30 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | -$1.14 10-Q · filed 2022-08-09 | -$2.34 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | -$1.20 10-Q · filed 2022-05-05 | ||||
| 2014-12-31 | $0.52 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$0.26 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$1.50 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$3.19 derived: net income ÷ weighted average shares · filed 2017-03-16 | |
| 2014-09-30 | -$31.00 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$49.56 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$67.65 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$84.07 derived: net income ÷ weighted average shares · filed 2016-03-14 | |
| 2014-06-30 | -$18.55 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$36.64 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$53.05 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$68.27 derived: net income ÷ weighted average shares · filed 2016-03-14 | |
| 2014-03-31 | -$18.09 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$34.50 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$49.71 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$63.14 derived: net income ÷ weighted average shares · filed 2016-03-14 | |
| 2013-12-31 | -$16.41 derived: net income ÷ weighted average shares · filed 2015-03-20 | -$31.62 derived: net income ÷ weighted average shares · filed 2015-03-20 | -$45.02 derived: net income ÷ weighted average shares · filed 2015-03-20 | -$59.67 derived: net income ÷ weighted average shares · filed 2016-03-14 | |
| 2013-09-30 | -$15.21 derived: net income ÷ weighted average shares · filed 2015-03-20 | -$28.58 derived: net income ÷ weighted average shares · filed 2015-03-20 | -$43.22 derived: net income ÷ weighted average shares · filed 2015-03-20 | ||
| 2013-06-30 | -$13.33 derived: net income ÷ weighted average shares · filed 2015-03-20 | -$27.97 derived: net income ÷ weighted average shares · filed 2015-03-20 | |||
| 2013-03-31 | -$14.64 derived: net income ÷ weighted average shares · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |